These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31015202)

  • 1. Repurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant
    Yang M; Schell MJ; Loboda A; Nebozhyn M; Li J; Teer JK; Pledger WJ; Yeatman TJ
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1141-1152. PubMed ID: 31015202
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Thota R; Yang M; Pflieger L; Schell MJ; Rajan M; Davis TB; Wang H; Presson A; Pledger WJ; Yeatman TJ
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
    Huemer F; Thaler J; Piringer G; Hackl H; Pleyer L; Hufnagl C; Weiss L; Greil R
    BMC Cancer; 2018 Jan; 18(1):11. PubMed ID: 29298682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients.
    Jeon CH; Lee HI; Shin IH; Park JW
    Int J Colorectal Dis; 2008 Jan; 23(1):29-35. PubMed ID: 17704924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coaltered
    Datta J; Smith JJ; Chatila WK; McAuliffe JC; Kandoth C; Vakiani E; Frankel TL; Ganesh K; Wasserman I; Lipsyc-Sharf M; Guillem J; Nash GM; Paty PB; Weiser MR; Saltz LB; Berger MF; Jarnagin WR; Balachandran V; Kingham TP; Kemeny NE; Cercek A; Garcia-Aguilar J; Taylor BS; Viale A; Yaeger R; Solit DB; Schultz N; D'Angelica MI
    Clin Cancer Res; 2020 Mar; 26(5):1077-1085. PubMed ID: 31719050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance Mechanisms to Anti-Epidermal Growth Factor Receptor Therapy in
    Parseghian CM; Sun R; Woods M; Napolitano S; Lee HM; Alshenaifi J; Willis J; Nunez S; Raghav KP; Morris VK; Shen JP; Eluri M; Sorokin A; Kanikarla P; Vilar E; Rehn M; Ang A; Troiani T; Kopetz S
    J Clin Oncol; 2023 Jan; 41(3):460-471. PubMed ID: 36351210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers.
    Scheel SK; Porzner M; Pfeiffer S; Ormanns S; Kirchner T; Jung A
    BMC Cancer; 2010 Aug; 10():413. PubMed ID: 20696052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer with and without microsatellite instability involves different genes.
    Salahshor S; Kressner U; Pâhlman L; Glimelius B; Lindmark G; Lindblom A
    Genes Chromosomes Cancer; 1999 Nov; 26(3):247-52. PubMed ID: 10502323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA alterations of microsatellite DNA, p53, APC and K-ras in Chinese colorectal cancer patients.
    Xu XM; Qian JC; Cai Z; Tang T; Wang P; Zhang KH; Deng ZL; Cai JP
    Eur J Clin Invest; 2012 Jul; 42(7):751-9. PubMed ID: 22324744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.
    Wang C; Ouyang C; Cho M; Ji J; Sandhu J; Goel A; Kahn M; Fakih M
    Oncologist; 2021 Mar; 26(3):208-214. PubMed ID: 33230914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy.
    Oden-Gangloff A; Di Fiore F; Bibeau F; Lamy A; Bougeard G; Charbonnier F; Blanchard F; Tougeron D; Ychou M; Boissière F; Le Pessot F; Sabourin JC; Tuech JJ; Michel P; Frebourg T
    Br J Cancer; 2009 Apr; 100(8):1330-5. PubMed ID: 19367287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative Ras pathway signature for cetuximab therapy reveals resistant mechanism in colorectal cancer.
    Song K; Lu H; Jin L; Wang K; Guo W; Zheng H; Li K; He C; You T; Fu Y; Yang J; Zhao W; Guo Z
    FEBS J; 2020 Dec; 287(23):5236-5248. PubMed ID: 32216031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and prognostic heterogeneity among RAS/BRAF
    Berg KCG; Brunsell TH; Sveen A; Alagaratnam S; Bjørnslett M; Hektoen M; Brudvik KW; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA
    Mol Oncol; 2021 Apr; 15(4):830-845. PubMed ID: 33325154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.
    Lind GE; Thorstensen L; Løvig T; Meling GI; Hamelin R; Rognum TO; Esteller M; Lothe RA
    Mol Cancer; 2004 Oct; 3():28. PubMed ID: 15476557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
    Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM
    Br J Cancer; 2015 Sep; 113(6):979-88. PubMed ID: 26305864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.
    Chun YS; Passot G; Yamashita S; Nusrat M; Katsonis P; Loree JM; Conrad C; Tzeng CD; Xiao L; Aloia TA; Eng C; Kopetz SE; Lichtarge O; Vauthey JN
    Ann Surg; 2019 May; 269(5):917-923. PubMed ID: 28767562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation Status of
    Kawaguchi Y; Kopetz S; Newhook TE; De Bellis M; Chun YS; Tzeng CD; Aloia TA; Vauthey JN
    Clin Cancer Res; 2019 Oct; 25(19):5843-5851. PubMed ID: 31221662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modeling the order of driver gene mutations in colorectal cancer.
    Li L; Hu Y; Xu Y; Tang S
    PLoS Comput Biol; 2023 Jun; 19(6):e1011225. PubMed ID: 37368936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of WEE1 Is Effective in
    Seligmann JF; Fisher DJ; Brown LC; Adams RA; Graham J; Quirke P; Richman SD; Butler R; Domingo E; Blake A; Yates E; Braun M; Collinson F; Jones R; Brown E; de Winton E; Humphrey TC; Parmar M; Kaplan R; Wilson RH; Seymour M; Maughan TS;
    J Clin Oncol; 2021 Nov; 39(33):3705-3715. PubMed ID: 34538072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.